Related Experiment Videos

Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington's disease mice.

A S Harris1, E M Denovan-Wright, L C Hamilton

  • 1Laboratory of Molecular Neurobiology, Department of Pharmacology, Dalhousie University, Halifax NS B3H 4H7.

Summary

Huntington's disease (HD) involves an expanded CAG repeat in the huntingtin gene. This study found decreased protein kinase C beta II (PKC beta II) mRNA in symptomatic HD mice, suggesting a role for PKC beta II in HD's molecular pathology.

Related Concept Videos